Sale!

Tamoxifen Citrate

Original price was: €49.99.Current price is: €39.99.

& Free Shipping
Guaranteed Safe Checkout

Tamoxifen Citrate: A Comprehensive Guide to Uses, Benefits, and Safety

Focus Keywords: Tamoxifen Citrate, Tamoxifen Citrate Uses, Tamoxifen Citrate Benefits, Tamoxifen Therapy, Breast Cancer Treatment, Selective Estrogen Receptor Modulator, Tamoxifen Side Effects, Hormone Therapy, Estrogen Receptor-Positive Breast Cancer, Tamoxifen Medication

H2: What Is Tamoxifen Citrate?

Tamoxifen Citrate is a widely prescribed medication used primarily in the treatment and prevention of certain types of breast cancer. It belongs to a class of drugs known as Selective Estrogen Receptor Modulators (SERMs). These medications work by blocking the effects of estrogen in breast tissue, helping to slow or stop the growth of cancer cells that depend on estrogen for development.

For decades, Tamoxifen Citrate has been considered a cornerstone of hormone therapy for patients diagnosed with estrogen receptor-positive (ER-positive) breast cancer. Healthcare professionals may also recommend it to individuals who are at a higher risk of developing breast cancer due to genetic factors, family history, or previous breast abnormalities.

Its effectiveness, extensive clinical research, and long history of use have made Tamoxifen Citrate one of the most trusted medications in modern oncology.

H2: How Tamoxifen Citrate Works

Tamoxifen Citrate functions by binding to estrogen receptors within breast tissue. By occupying these receptors, it prevents estrogen from attaching and stimulating the growth of hormone-sensitive cancer cells.

Unlike some treatments that completely suppress estrogen production, Tamoxifen acts selectively. While it blocks estrogen activity in breast tissue, it may have estrogen-like effects in other parts of the body, such as the bones and uterus. This unique mechanism helps provide therapeutic benefits while maintaining certain physiological functions.

Because of its targeted action, Tamoxifen Citrate is frequently prescribed as part of long-term treatment plans that may last five to ten years, depending on a patient’s diagnosis and risk profile.

H2: Key Benefits of Tamoxifen Citrate

Tamoxifen Citrate offers several important benefits for patients undergoing hormone therapy. One of its primary advantages is its proven ability to reduce the risk of breast cancer recurrence after surgery, chemotherapy, or radiation treatment.

Additional benefits include:

H3: Reduction in Cancer Recurrence

Clinical studies have demonstrated that Tamoxifen can significantly lower the likelihood of breast cancer returning in patients with hormone receptor-positive disease.

H3: Prevention in High-Risk Individuals

For people with an elevated risk of breast cancer, Tamoxifen Citrate may help reduce the chances of developing the disease in the future.

H3: Improved Long-Term Survival

Long-term use of Tamoxifen has been associated with improved survival rates among many breast cancer patients, making it a critical component of comprehensive cancer care.

H3: Bone Health Support

In some postmenopausal women, Tamoxifen may help maintain bone density, reducing the risk of osteoporosis and fractures.

H2: Common Side Effects and Safety Considerations

Like all medications, Tamoxifen Citrate may cause side effects. While many individuals tolerate the treatment well, understanding potential adverse effects is essential for informed decision-making.

H3: Common Side Effects

Frequently reported side effects may include:

  • Hot flashes
  • Night sweats
  • Fatigue
  • Mood changes
  • Nausea
  • Vaginal discharge or dryness
  • Menstrual irregularities

H3: Serious Safety Concerns

Although uncommon, some patients may experience more serious complications, including:

  • Blood clots
  • Stroke
  • Changes in vision
  • Uterine abnormalities
  • Liver-related issues

Patients should maintain regular follow-up appointments and discuss any unusual symptoms with their healthcare provider promptly.

H4: Monitoring During Treatment

Routine medical evaluations are often recommended during Tamoxifen therapy. These assessments may include physical examinations, imaging studies, and laboratory tests to ensure treatment effectiveness and monitor overall health.

H2: Who May Benefit from Tamoxifen Citrate?

Tamoxifen Citrate is commonly prescribed for:

  • Individuals with estrogen receptor-positive breast cancer
  • Patients receiving adjuvant hormone therapy after surgery
  • People at high risk of developing breast cancer
  • Certain patients with metastatic breast cancer
  • Individuals requiring preventive breast cancer treatment strategies

The suitability of Tamoxifen depends on various factors, including age, medical history, menopausal status, and overall treatment goals. Healthcare professionals carefully evaluate these factors before initiating therapy.

H2: Conclusion

Tamoxifen Citrate remains one of the most effective and extensively studied hormone therapies available for breast cancer treatment and prevention. By selectively blocking estrogen activity in breast tissue, it helps reduce cancer recurrence, improve survival outcomes, and lower breast cancer risk in eligible individuals.

While the medication offers substantial clinical benefits, patients should be aware of potential side effects and the importance of ongoing medical monitoring. When used under professional supervision, Tamoxifen Citrate continues to play a vital role in modern breast cancer management and long-term patient care.

CID

2733525

CAS

54965-24-1

InChI

InChI=1S/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13, 5(11)12)2-4(9)10/h5-18H, 4, 19-20H2, 1-3H3;13H, 1-2H2, (H, 7, 8)(H, 9, 10)(H, 11, 12)/b26-25-;

InChIKey

FQZYTYWMLGAPFJ-OQKDUQJOSA-N

Isomeric SMILES

CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

Canonical SMILES

CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

IUPAC Name

2-[4-[(Z)-1, 2-diphenylbut-1-enyl]phenoxy]-N, N-dimethylethanamine;2-hydroxypropane-1, 2, 3-tricarboxylic acid

Molecular Formula

C32H37NO8

Molecular Weight

563.6

Monoisotopic Mass

563.25191714

Polar Area

145

Complexity

690

Heavy Atom Count

41

Hydrogen Bond Donor Count

4

Hydrogen Bond Acceptor Count

9

Rotatable Bond Count

13

Physical Appearance

White Opaque Liquid

Stability

Room Temperature